At the end of the call, somebody jokingly said BTX is a stem cell monopoly. Basically, if someone wants anything to do with stem cells, BTX has it covered. It is amazing, from research to clinical trials. It has its hand in everything.
So other than the avoidance and nonsense, that $900k in 2012 for the "monpoly" is going to grow at what rate?
Take a few large whiffs of nitrous oxide and pretend it's 50% a year. How man years until that covers $10mm in G&A?????
In the meantime, BTX is losing $35mm a year, with